drugset / Trial / NCT02216227

Checklist to Prevent MRSA Surgical Site Infections

NCT02216227 ↗

Completed 23005 enrolled VA Office of Research and Development
NaSingle-groupOpen-labelPrevention

Summary

The goals of this project are 1) to assess the effectiveness and cost-effectiveness of the checklist to prevent MRSA SSIs among Veterans undergoing TJA or cardiac surgery, and 2) to assess barriers and facilitators to checklist implementation. Hypotheses: 1. The SSI checklist will be effective at reducing MRSA SSIs among total joint arthroplasty and cardiac surgery patients. 2. Implementation of the checklist will be associated with an overall reduction in SSIs caused by all pathogens. 3. The SSI Checklist will be cost-saving since it will prevent many expensive SSIs. 4. Preoperative MRSA testing will be a modifiable barrier to implementing the SSI checklist.

Timeline

Start
2014-04-01
Primary completion
2021-02-28
Completion
2021-02-28

Outcome

Missed primary endpoint

registry analysis (superiority test); Surgical Site Infection Checklist; p = 0.13; Regression, Logistic NCT02216227 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefazolin Small molecule — —
Subject Chlorhexidine gluconate Other / unclassified — Topical
Subject Mupirocin Small molecule — Intranasal
Subject Nasal Povidone Iodine Unknown — Intranasal
Subject Vancomycin Other / unclassified — —

Indications

No indication recorded.